Switch to:
More From Other Websites
Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for... Sep 26 2016
Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for... Sep 26 2016
Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for... Sep 26 2016
[$$] Rodin Therapeutics, a Neurology Drug Firm, Expands Management Team Sep 23 2016
Top 5 profitable Biotech stocks : September 23, 2016 Sep 23 2016
Biogen Bets on Nusinersen (BIIB, IONS) Sep 22 2016
Amazon (AMZN), Charter Communications (CHTR) And 3 Other Hot Stocks That Billionaire Ken Griffin Is... Sep 21 2016
Gilead Sciences: Allergan's Next Target? Sep 21 2016
Orphan Drug Designation among Latest Happenings at Ionis Sep 21 2016
Stocks Close Barely Higher Ahead Of Fed Announcement; Biotechs Aid Nasdaq Sep 20 2016
Applied Genetic Technologies Is an Attractive Acquisition Target for Allergan or Biogen Sep 20 2016
Biogen: You Mean There's Hope? Sep 16 2016
New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA™ (Daclizumab) and Support Long-Term... Sep 15 2016
New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA™ (Daclizumab) and Support Long-Term... Sep 15 2016
New Data Presented at ECTRIMS Reinforce Efficacy of ZINBRYTA™ (Daclizumab) and Support Long-Term... Sep 15 2016
Biogen to Report Third Quarter 2016 Financial Results on October 26, 2016 Sep 14 2016
Biogen to Report Third Quarter 2016 Financial Results on October 26, 2016 Sep 14 2016
Biogen (BIIB) Stock Gains on Positive Multiple Sclerosis Drug Data Sep 14 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK